Assessment of Systemically Administered Torisel Delivery to Brain Tumors by Intratumoral Microdialysis.

Trial Profile

Assessment of Systemically Administered Torisel Delivery to Brain Tumors by Intratumoral Microdialysis.

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 20 Nov 2013

At a glance

  • Drugs Temsirolimus (Primary)
  • Indications Astrocytoma; Glioblastoma; Glioma
  • Focus Pharmacokinetics
  • Most Recent Events

    • 15 Jul 2010 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 10 Aug 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top